James Linder, M.D.

Department Affiliations
Professor

I have served on the UNMC faculty since 1983, having held numerous administrative positions in the Department of Pathology and Microbiology, College of Medicine Dean’s Office and UNMC Chancellor's Office. Currently, my principle appointment is in the University of Nebraska Central Administration, serving as Senior Associate to the President for Innovation and Economic Competitiveness. Separately, I serve as President of the University Technology Development Corporation that oversees technology development for the University of Nebraska.

Interests
Digital pathology and computer imaging, Hematology, Cytopathology, Technology Transfer and Development

My academic interests have been in cytopathology, focused on improving diagnostics, by using automated techniques.  I have secondary, but strong interest in immunochemistry, molecular diagnostics, and computer-aided instruction

Education and Training
B.S. Biochemistry and Microbiology, Iowa State University of Science and Technology, 1976
M.D. (with Distinction) University of Nebraska College of Medicine, 1980
Pathology Resident, Duke University Medical Center, July 1980 - Sept. 1982
Pathology Resident, University of Nebraska Medical Center, Oct. 1982 - Nov. 1983

Teaching Activities
Clinical: Cytopathology

National Activities
Finance Committee, United States and Canadian Academy of Pathology
"Israel Davidsohn Award for Distinguished Service"; American Society of Clinical Pathologists
"Distinguished Teaching Award" by the UNMC College of Medicine
"Award for Excellence in Medical Publications" from the American Medical Writers Association.
Council, United States & Canadian Academy of Pathology 1998-2004.
President, American Society Clinical Pathology, 1998-1999
Editorial Boards:
Modern Pathology (Assoc. Editor); Analytical and Quantitative Cytology and Cytopathology ; Diagnostic Cytopathology; Editorial Advisory Board for Atlas of Tumor Pathology 4th Series; American Journal of Clinical Pathology; Archives of Pathology and Laboratory Medicine
External Activities:
Medical Director, Cytyc Corporation, Marlborough, MA

Notable Publications
Linder, J Molecular diagnostic in cervical cancer screening. Acta Cytologica Supplement 2 51:275, 2007.

Linder, J, Derzko, A. Sneider, N. Increased detection of cervical abnormality with the ThinPrep Imaging System:  A comparative analysis of over one million Pap Tests.  Cancer Cytopathology Supplement 108, 2006.

C. Leng, J. Linder, K. Linder, L. Burg.  Aliquot removal from ThinPrep specimens: Effect on adequacy and cytological diagnosis. Cancer Cytopathology Supplement 105, 2005.

J. Meyer, K. Bisgaard, B. Andersen, O. Rasmussen, D. Hanlon, J. Linder, E. Cibas. Evaluation of the CINtec assay for detection of p16INK4a in ThinPrep specimens and correlation to biopsy follow-up results. Cancer Cytopathology Supplement 105, 2005.

Monsonego J,  Bosch FX, Coursaget  P, Cox JT, Linder J, et al.  Cervical cancer control, priorities and new directions. Int J Cancer. 2004 Jan 20;108(3):329-33.

Linder, J. Is it reality or an illusion that liquid-based cytology is better than conventional cervical smears? Cytopathology. 2002 Feb;13(1):66.

Linder, J.  The ThinPrep Pap Test: Spring 1998 Update.  Genital Infections & Neoplasia
1:16-18, 1998.

Linder, J.  Recent advances in thin-layer cytology.  Diagnostic Cytopathology 18:24-32, 1998.

For a detailed list of publications, click here.

James Linder, M.D.
Dr. James Linder
Email Address
jlinder@nebraska.edu

Mailing Address
University of Nebraska at Omaha
134Q Mammel Hall
6708 Pine Street
Omaha, NE 68182-0048

Office Location
134Q Mammel Hall, UNO South Campus

Phone Numbers
Office: 402-554-2373

;